智能远程医疗在药物警戒中的未来展望
药物警戒通过检测和预防药物不良事件提升患者安全,但存在数据来源分散、不良事件漏报或误报等挑战。人工智能(包括自然语言处理和深度学习等机器学习方法)可自动检测和提取不良事件信息,优化药物警戒流程。随着远程医疗服务需求增加,人工智能在远程医疗中检测和预防不良事件方面可发挥作用。
要点
- 人工智能可自动化药物警戒流程,提升已知不良事件的监测效率
- 远程医疗场景中人工智能有助于检测和预防药物不良事件
- 当前药物警戒面临数据获取困难和不良事件漏报、误报的挑战
核心结论
- 人工智能方法可自动化药物警戒流程并改善对已知和记录在案的不良事件的监测
- 人工智能在远程医疗实践中可发挥检测和预防药物不良事件的作用
研究设计与样本
- 综述文章,讨论人工智能方法改善药物警戒质量及在远程医疗中作用的两个用例
主要发现
- 药物警戒通过检测和预防药物不良事件改善患者安全
- 存在限制不良事件检测的挑战,导致许多不良事件被漏报或误报
- 挑战包括从电子健康记录和可穿戴医疗设备等多种来源获取大型数据集
- 人工智能包括机器学习方法如自然语言处理和深度学习,可检测和提取不良事件信息
临床怎么用
- 可利用人工智能方法自动化药物警戒流程,改善对已知和记录在案的不良事件的监测
- 在远程医疗服务中可应用人工智能方法检测和预防药物不良事件
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pharmacovigilance improves patient safety by detecting and preventing adverse drug events. However, challenges exist that limit adverse drug event detection, resulting in many adverse drug events being underreported or inaccurately reported. One challenge includes having access to large data sets from various sources including electronic health records and wearable medical devices. Artificial intelligence, including machine learning methods, such as natural language processing and deep learning, can detect and extract information about adverse drug events, thus automating the pharmacovigilance process and improving the surveillance of known and documented adverse drug events. In addition, with the increased demand for telehealth services, for managing both acute and chronic diseases, artificial intelligence methods can play a role in detecting and preventing adverse drug events. In this review, we discuss two use cases of how artificial intelligence methods may be useful to improve the quality of pharmacovigilance and the role of artificial intelligence in telehealth practices.
引用
- Edrees H, Song W, Syrowatka A, et al. Intelligent Telehealth in Pharmacovigilance: A Future Perspective. Drug Saf. 2022. PMID: 35579810. doi:10.1007/s40264-022-01172-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。